Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies
Merola J, Warren R, Thaçi D, Gordon K, Nishida E, Strober B, Conrad C, Kavanagh S, López Pinto J, Hoepken B, Gisondi P. Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies. American Journal Of Clinical Dermatology 2025, 1-13. PMID: 40886218, DOI: 10.1007/s40257-025-00968-2.Peer-Reviewed Original ResearchOpen-label extensionNail clearanceNail Psoriasis Severity IndexComparator-treated patientsPhase III trialsPhase IIIb trialProportion of patientsPsoriasis Severity IndexNon-responder imputationLong-term treatmentIII trialsBimekizumabComplete skinComplete clearanceSustained long-termNail psoriasisActive comparatorPsoriatic arthritisComparative efficacyBE SUREUstekinumabEmotional Well-BeingSecukinumabAdalimumabRisk factors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply